ICD-10-PCS Codes

• 1 3E03002 (INTRODUCTION OF HIGH-DOSE INTERLEUKIN-2 INTO PERIPHERAL VEIN, OPEN APPROACH)

• 2 3E03003 (INTRODUCTION OF LOW-DOSE INTERLEUKIN-2 INTO PERIPHERAL VEIN, OPEN APPROACH)

• 3 3E03005 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PERIPHERAL VEIN, OPEN APPROACH)

• 4 3E0300M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PERIPHERAL VEIN, OPEN APPROACH)

• 5 3E0300P (INTRODUCTION OF CLOFARABINE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 6 3E03016 (INTRODUCTION OF RECOMBINANT HUMAN-ACTIVATED PROTEIN C INTO PERIPHERAL VEIN, OPEN)

• 7 3E03017 (INTRODUCTION OF OTHER THROMBOLYTIC INTO PERIPHERAL VEIN, OPEN APPROACH)

• 8 3E03028 (INTRODUCTION OF OXAZOLIDINONES INTO PERIPHERAL VEIN, OPEN APPROACH)

• 9 3E03029 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 10 3E0303Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO PERIPHERAL VEIN, OPEN APPROACH)

• 11 3E0304Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 12 3E0306Z (INTRODUCTION OF NUTRITIONAL SUBSTANCE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 13 3E0307Z (INTRODUCTION OF ELECTROLYTIC AND WATER BALANCE SUBSTANCE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 14 3E030FZ (INTRODUCTION OF INTRACIRCULATORY ANESTHETIC INTO PERIPHERAL VEIN, OPEN APPROACH)

• 15 3E030GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 16 3E030GN (INTRODUCTION OF BLOOD BRAIN BARRIER DISRUPTION SUBSTANCE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 17 3E030HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 18 3E030KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 19 3E030NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO PERIPHERAL VEIN, OPEN APPROACH)

• 20 3E030PZ (INTRODUCTION OF PLATELET INHIBITOR INTO PERIPHERAL VEIN, OPEN APPROACH)

• 21 3E030RZ (INTRODUCTION OF ANTIARRHYTHMIC INTO PERIPHERAL VEIN, OPEN APPROACH)

• 22 3E030TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO PERIPHERAL VEIN, OPEN APPROACH)

• 23 3E030U0 (INTRODUCTION OF AUTOLOGOUS PANCREATIC ISLET CELLS INTO PERIPHERAL VEIN, OPEN APPROACH)

• 24 3E030U1 (INTRODUCTION OF NONAUTOLOGOUS PANCREATIC ISLET CELLS INTO PERIPHERAL VEIN, OPEN APPROACH)

• 25 3E030VG (INTRODUCTION OF INSULIN INTO PERIPHERAL VEIN, OPEN APPROACH)

• 26 3E030VH (INTRODUCTION OF HUMAN B-TYPE NATRIURETIC PEPTIDE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 27 3E030VJ (INTRODUCTION OF OTHER HORMONE INTO PERIPHERAL VEIN, OPEN APPROACH)

• 28 3E030WK (INTRODUCTION OF IMMUNOSTIMULATOR INTO PERIPHERAL VEIN, OPEN)

• 29 3E030WL (INTRODUCTION OF IMMUNOSUPPRESSIVE INTO PERIPHERAL VEIN, OPEN)

• 30 3E030XZ (INTRODUCTION OF VASOPRESSOR INTO PERIPHERAL VEIN, OPEN APPROACH)

• 31 3E03302 (INTRODUCTION OF HIGH-DOSE INTERLEUKIN-2 INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 32 3E03303 (INTRODUCTION OF LOW-DOSE INTERLEUKIN-2 INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 33 3E03305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 34 3E0330M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 35 3E0330P (INTRODUCTION OF CLOFARABINE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 36 3E03316 (INTRODUCTION OF RECOMBINANT HUMAN-ACTIVATED PROTEIN C INTO PERIPHERAL VEIN, PERCUTANEOUS)

• 37 3E03317 (INTRODUCTION OF OTHER THROMBOLYTIC INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 38 3E03328 (INTRODUCTION OF OXAZOLIDINONES INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 39 3E03329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 40 3E0333Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 41 3E0334Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 42 3E0336Z (INTRODUCTION OF NUTRITIONAL SUBSTANCE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 43 3E0337Z (INTRODUCTION OF ELECTROLYTIC AND WATER BALANCE SUBSTANCE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 44 3E033FZ (INTRODUCTION OF INTRACIRCULATORY ANESTHETIC INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 45 3E033GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 46 3E033GN (INTRODUCTION OF BLOOD BRAIN BARRIER DISRUPTION SUBSTANCE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 47 3E033GQ (INTRODUCTION OF GLUCARPIDASE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 48 3E033GR (INTRODUCTION OF OTHER THERAPEUTIC MONOCLONAL ANTIBODY INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 49 3E033HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 50 3E033KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 51 3E033NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 52 3E033PZ (INTRODUCTION OF PLATELET INHIBITOR INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 53 3E033RZ (INTRODUCTION OF ANTIARRHYTHMIC INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 54 3E033TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 55 3E033U0 (INTRODUCTION OF AUTOLOGOUS PANCREATIC ISLET CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 56 3E033U1 (INTRODUCTION OF NONAUTOLOGOUS PANCREATIC ISLET CELLS INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 57 3E033VG (INTRODUCTION OF INSULIN INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 58 3E033VH (INTRODUCTION OF HUMAN B-TYPE NATRIURETIC PEPTIDE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 59 3E033VJ (INTRODUCTION OF OTHER HORMONE INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)

• 60 3E033WK (INTRODUCTION OF IMMUNOSTIMULATOR INTO PERIPHERAL VEIN, PERCUTANEOUS)

• 61 3E033WL (INTRODUCTION OF IMMUNOSUPPRESSIVE INTO PERIPHERAL VEIN, PERCUTANEOUS)

• 62 3E033XZ (INTRODUCTION OF VASOPRESSOR INTO PERIPHERAL VEIN, PERCUTANEOUS APPROACH)